XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Capital Stock [Member]
Other Equity [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Non-controlling Interests [Member]
Statutory Surplus Reserve [Member]
Balance, beginning of period at Dec. 31, 2020   $ 407,020 $ 188,845 $ (202,849) $ 988    
Movement of Shareholders' Equity              
Employee stock options exercised, net of shares withheld for employee tax obligations   824          
Amortization of share-based payment expense - stock options     391        
Amortization of share-based payment expense - restricted share units     3,486        
Amortization of share-based payment expense - performance stock units     1,087        
Restricted share units vested   6,885 (10,318)        
Purchase of capped calls related to convertible notes     (19,067)        
Grant date fair value of stock options exercised   253 (253)        
Net loss attributable to common shareholders $ (14,840)     (14,840)      
Other comprehensive income (loss), net of tax (2,100)       (1,447)    
Balance, end of period at Mar. 31, 2021   414,982 164,171 (217,689) (459)    
Balance, beginning of period at Dec. 31, 2020           $ 70,004  
Movement of Shareholders' Equity              
Net income (loss) attributable to non-controlling interests 4,340         4,349  
Other comprehensive income (loss), net of tax           (653)  
Share-based compensation attributable to non-controlling interests           (3)  
Balance, end of period at Mar. 31, 2021           73,697  
Movement of Shareholders' Equity              
Total shareholders' equity 434,702            
Total shareholders' equity 429,614            
Balance, beginning of period at Dec. 31, 2021 356,083 409,979 174,620 (234,975) 2,527   $ 3,932
Movement of Shareholders' Equity              
Amortization of share-based payment expense - stock options     231        
Amortization of share-based payment expense - restricted share units     4,350        
Amortization of share-based payment expense - performance stock units     1,854        
Restricted share units vested   9,045 (12,600)        
Common shares repurchased and retired   (3,662)   (2,610)      
Change in ownership interest related to IMAX China common share repurchases     (543)     (1,301)  
Net loss attributable to common shareholders (13,609)     (13,609)      
Other comprehensive income (loss), net of tax 868       701    
Balance, end of period at Mar. 31, 2022 339,240 $ 415,362 $ 167,912 $ (251,194) $ 3,228   $ 3,932
Balance, beginning of period at Dec. 31, 2021 73,531         73,531  
Movement of Shareholders' Equity              
Net income (loss) attributable to non-controlling interests 1,659         1,656  
Other comprehensive income (loss), net of tax           167  
Share-based compensation attributable to non-controlling interests           28  
Balance, end of period at Mar. 31, 2022 74,081         $ 74,081  
Movement of Shareholders' Equity              
Total shareholders' equity $ 413,321